JSE:APN has been consolidating since June, the stock is now at an area of value, at a potential resistance level. Waiting to see if it can break above, it'll be interesting above R165/share.
Catalent Short Term - We look to Buy at 63.84 (stop at 56.95) The primary trend remains bearish. Bespoke support is located at 63.30. Support could prove difficult to breakdown. We look for a temporary move lower. Preferred trade is to buy on dips. Our profit targets will be 82.27 and 88.00 Resistance: 82.50 / 100.00 / 120.00 Support: 63.30 / 48.00 /...
Moderna Inc (MRNA), a much discussed stock over the previous years, is having a +8% day, a very encouraging since following the rejection on the 1D MA50 (blue trend-line) three days ago. What's more interesting is that we have seen almost the same pattern in the stock's all time lows in 2019. As you see, the price since September has been on Lower Lows while the...
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine...
Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS ) Sector: Health Technology (Pharmaceuticals: Major) Current Price: $46.36 Breakout price trigger: $47.85 Buy Zone (Top/Bottom Range): $44.65-$39.75 Price Target: $55.50-$56.30 Estimated Duration to Target: 131-139d Contract of Interest: $IONS 1/20/23 50c Trade price as of publish date: $3.20/cnt
Bristol-Myers Squibb Co Short Term - We look to Buy a break of 72.34 (stop at 70.99) Price action has formed a bullish ascending triangle formation. This is positive for sentiment and the uptrend has potential to return. Neckline resistance 72.00. A break of the neckline is required to confirm the formation. Further upside is expected. Our profit targets...
This is one of the stocks I hold indefinitely for dividends. we're at the bottom of our current channel and a double bottom is forming in a major area of support. In my previous post I stated my accumulation sections are in the lower end of the channel, so this is prime real estate to enter. Momentum downwards has come to a halt and I believe we will retest the...
The technical figure Triangle can be found in the daily chart in the German company F. Hoffmann-La Roche AG (ROG.vx). Roche is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. Roche is the fifth largest...
JSE:APN mini rally following a positive trading statement quickly fizzled. Aspen JSE:APN reporters that EPS will be between 32% - 37%. Audited results are coming this week, the numbers are expected to remain the same. The share is trading below key levels, the stock will need great numbers to push the price up, a promising setup is the price trading above...
1) The US recession talks are rising day by day. The recession is to come, we just don't know when, but it will come. 2) Inflation is at an all-time high. The IT sector is tanking like anything. 3) The Pharma sector is known to be recession-proof and inflation-proof. People will never stop spending on medicine and healthcare, no matter how expensive it gets. 4)...
NASDAQ:CVAC I hope you have enjoyed the global lie called 'Democracy' spread by US and EU and enjoy the death of your friends and family, It was only to fill the pockets of those who donate money to political campaigns. Headlines: Nov 10, 2016: Welcome To 2030: I Own Nothing, Have No Privacy And Life Has Never Been Better (Forbes). Sep 24, 2018 :...
The technical figure Triangle can be found in the Belgium company Galapagos NV (GLPG.as) at daily chart. Galapagos NV (formerly known as Galapagos Genomics) is a Belgian pharmaceutical research company which was founded in 1999. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and...
GlaxoSmithKlein (GSK) just formed a Death Cross on the 1D time-frame, which is when the 1D MA50 (blue trend-line) crosses below the 1D MA200 (orange trend-line). This is technically a bearish pattern but last time it formed (March 24 2020) was exactly on the bottom of the COVID crash and the price recovered rapidly. That was of course in the aftermath of the...
Eli Lilly and Company ( NYSE:LLY ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $315.073B Current Price: $331.60 Breakout price: $334.70 Buy Zone (Top/Bottom Range): $314.00-$292.90 Price Target: $364.20-$367.50 (2nd) Estimated Duration to Target: 112-120d (2nd) Contract of Interest: $LLY 10/21/22 350c Trade price as of publish...
Novavax NVAX is actually lining up pretty well... from about 240, it tanked to 40, and on Friday, it gained 11% to close the week at 57.15. This caught my attention as it cleanly broke out of trendlines, breaking out also from a bearish divergence, on BOTH the weekly and daily chart. IMHO, it appears to be in technical and fractal alignment. Weekly chart...
NASDAQ:VRTX is on a verge of a breakout. AMEX:XPH is also staging a recovery, but still trading below key levels. For now, the focus in on a NASDAQ:VRTX look position.
The statistics are between $184 - $219(1 Year) Its Financial Health is very strong. Why not wait till Moderna makes greater progress and finds It Resistance Again at $450 Moderna has many projects running. So if we see progress in some of the projects in the next Years, we will see a great price rise. I believe it won't be difficult to reach its older...
The Statistics say between $182-$253 (1 year) This Looks like it can Happen in 1 Year. That will depend on their Progress. Let's see what will happen in 2023, but it looks ok to hold for the next 5 Years or more BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022 BioNTech is...